Artelo Biosciences, Inc.

ARTL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014
Assets
Cash & Equivalents $572.8K $3.6K $17.0K $14.7K
Accounts Receivable — — — —
Inventory — — — —
Total Current Assets $574.3K $3.6K $17.0K $14.7K
Property, Plant & Equipment — — — —
Goodwill — — — —
Intangible Assets (Excl. Goodwill) — — — —
Total Assets $574.3K $3.6K $17.0K $14.7K
Liabilities
Accounts Payable — — — —
Total Current Liabilities $29.4K $17.4K $1.7K —
Long-Term Debt — — — —
Total Liabilities $29.4K $17.4K $1.7K $0
Stockholders' Equity
Retained Earnings $-295.1K $-60.2K $-30.5K $-15.3K
Total Stockholders' Equity $544.8K $-13.8K $15.9K $14.7K
← Newer Page 2 of 2 Older →